Overview

Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
0
Participant gender:
Female
Summary
This study is for compare the efficacy of two different regimens(vaginal vs intramuscular) of progesterone therapy in prevention of preterm birth in high risk pregnant women.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ewha Womans University Mokdong Hospital
Collaborators:
Han Wha Pharma Co., Ltd.
Ministry of Health & Welfare, Korea
Samsung Medical Center
Treatments:
Progesterone
Criteria
Inclusion Criteria:

- With a history of prior spontaneous preterm birth or short cervix length

- Spontaneous preterm birth: preterm birth <37 weeks of gestation due to spontaneous
preterm labor or preterm premature rupture of membranes (PPROM)

- Short Cervix length : cervix length <25 mm as measured by transvaginal ultrasound at
16-24 weeks of gestation

Exclusion Criteria:

- Multiple gestations

- Major congenital anomalies

- Elective prophylactic cervical cerclage <16 weeks of gestation during current
pregnancy

- Previous intentional preterm birth due to maternal or fetal indications, such as
preeclampsia and fetal growth restriction

- Diabetes, hypertension, other severe medical diseases